X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11) 11
index medicus (11) 11
female (8) 8
immunology (8) 8
male (8) 8
transplantation (6) 6
adult (5) 5
animals (4) 4
article (4) 4
hematology (4) 4
macrophages (4) 4
macrophages - immunology (4) 4
mice (4) 4
middle aged (4) 4
t cells (4) 4
activation (3) 3
aged (3) 3
analysis (3) 3
cancer (3) 3
cohort studies (3) 3
cytokines (3) 3
cytomegalovirus (3) 3
cytomegalovirus infections (3) 3
dendritic cells (3) 3
epidemiology (3) 3
gene expression regulation - immunology (3) 3
hematology, oncology and palliative medicine (3) 3
immunoglobulin j recombination signal sequence-binding protein - immunology (3) 3
infectious diseases (3) 3
oncology (3) 3
retrospective studies (3) 3
stem cells (3) 3
abridged index medicus (2) 2
adjuvant treatment (2) 2
adolescent (2) 2
antiviral agents (2) 2
biological response modifiers (2) 2
breast cancer (2) 2
cell polarity - immunology (2) 2
cell proliferation (2) 2
chemotherapy (2) 2
child (2) 2
child, preschool (2) 2
chronic myelogenous leukemia (2) 2
chronic myeloid leukemia (2) 2
clinical trials (2) 2
cmv viremia (2) 2
cognitive ability (2) 2
cytomegalovirus infections - prevention & control (2) 2
disease (2) 2
erbb-2 protein (2) 2
gata3 expression (2) 2
gene expression (2) 2
health aspects (2) 2
hematopoietic stem cell transplantation (2) 2
hematopoietic stem cell transplantation - adverse effects (2) 2
hematopoietic stem cell transplantation - methods (2) 2
hematopoietic stem cells (2) 2
immunoglobulin j recombination signal sequence-binding protein - metabolism (2) 2
incidence (2) 2
interferon (2) 2
leukemia, myelogenous, chronic, bcr-abl positive - therapy (2) 2
macrophages - metabolism (2) 2
magnetic resonance imaging (2) 2
mice, inbred c57bl (2) 2
neutropenia (2) 2
open-label (2) 2
paclitaxel (2) 2
pathological complete response (2) 2
pathway (2) 2
patients (2) 2
physiological aspects (2) 2
plus trastuzumab (2) 2
receptors, notch - metabolism (2) 2
research (2) 2
signal transduction (2) 2
signal transduction - immunology (2) 2
survival (2) 2
therapy (2) 2
toll-like receptors - metabolism (2) 2
trastuzumab (2) 2
treatment outcome (2) 2
up-regulation (2) 2
viremia (2) 2
virus diseases (2) 2
young adult (2) 2
5-fluorouracil (1) 1
adjuvant endocrine therapy (1) 1
adjuvant trastuzumab (1) 1
adults (1) 1
age (1) 1
age differences (1) 1
age factors (1) 1
aging (1) 1
aids/hiv (1) 1
alzheimers disease (1) 1
alzheimers-disease (1) 1
animal biochemistry (1) 1
anthracycline (1) 1
anthracyclines (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Immunology, ISSN 1529-2908, 07/2012, Volume 13, Issue 7, pp. 642 - 650
Journal Article
The Lancet Oncology, ISSN 1470-2045, 07/2019, Volume 20, Issue 7, pp. e390 - e396
Important results are emerging from clinical trials showing that surgery followed by chemotherapy might not be the optimal strategy to maximise a patient's... 
CARBOPLATIN | PREOPERATIVE CHEMOTHERAPY | THERAPY | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | LYMPH-NODE SURGERY | LONG-TERM OUTCOMES | OPEN-LABEL | PLUS TRASTUZUMAB | PATHOLOGICAL COMPLETE RESPONSE | PACLITAXEL | Medical colleges | Relapse | Adjuvant treatment | Estrogen | Breast cancer | Metastasis | Cancer | Diseases
Journal Article
蛋白质与细胞:英文版, ISSN 1674-800X, 2016, Volume 7, Issue 3, pp. 201 - 209
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 06/2019, Volume 37, Issue 16, pp. 1365 - 1365
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 6/2018, Volume 169, Issue 2, pp. 333 - 340
The purpose of this two-cohort Phase II trial was to estimate the pathologic complete response (pCR: ypT0/is ypN0) rate when trastuzumab plus pertuzumab are... 
Neoadjuvant therapy | HER-2-positive | Medicine & Public Health | Pertuzumab | Pathological complete response | Oncology | Breast cancer | Trastuzumab | MULTICENTER | OPEN-LABEL | COMBINATION | PLUS TRASTUZUMAB | CHEMOTHERAPY | ADJUVANT TRASTUZUMAB | LAPATINIB | THERAPY | ONCOLOGY | CLINICAL-TRIALS | CONCURRENT | Cyclophosphamide - administration & dosage | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Epirubicin - administration & dosage | Cyclophosphamide - adverse effects | Drug-Related Side Effects and Adverse Reactions - pathology | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Adult | Female | Paclitaxel - administration & dosage | Taxoids - adverse effects | Breast Neoplasms - epidemiology | Antibodies, Monoclonal, Humanized - adverse effects | Paclitaxel - adverse effects | Trastuzumab - adverse effects | Trastuzumab - administration & dosage | Breast Neoplasms - drug therapy | Taxoids - administration & dosage | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Neoadjuvant Therapy - adverse effects | Bridged-Ring Compounds - adverse effects | Bridged-Ring Compounds - administration & dosage | Drug-Related Side Effects and Adverse Reactions - classification | Epirubicin - adverse effects | Anthracyclines | Cyclophosphamide | Analysis | Adjuvant treatment | Clinical trials | Product development | Health aspects | Cancer
Journal Article
Transplant Infectious Disease, ISSN 1398-2273, 06/2018, Volume 20, Issue 3, pp. e12881 - n/a
Journal Article
Immunity, ISSN 1074-7613, 11/2008, Volume 29, Issue 5, pp. 691 - 703
Journal Article
Journal Article
Open Forum Infectious Diseases, ISSN 2328-8957, 12/2016, Volume 3, Issue suppl_1
Journal Article
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 04/2019, p. JCO1801933
Journal Article
by Guo, Shengwen and Lai, Chunren and Wu, Congling and Cen, Guiyin and Hariharan, A and Vijayakumari, Anupa A and Aarabi, Mohammad Hadi and Aballi, John and Nour, Abd Elazeim Abd Alla Mohamed and Abdelaziz, Mohammed and Abdolalizadeh, AmirHussein and Abdollahi, Mahsa and Abdul Aziz, Siti Aishah and Salam, Amritha Abdul and Abdulaziz, Nidhal and Abdulkadir, Ahmed and Abdullah, Sachal and Abdullah, Osama and Abrigo, Jill and Adachi, Noriaki and Adamson, Christopher and Adduru, Viraj and Adel, Tameem and Aderghal, Karim and Ades-Aron, Benjamin and Adeyosoye, Michael and Adlard, Paul and Srinivasa, Ag and Aganj, Iman and Agarwal, Ayush and Agarwal, Anupam and Agarwal, Anchit and Aguero, Cinthya and Aguiar, Pablo and Ahdidan, Jamila and Ahmad, Fayyaz and Ahmad, Rziwan and Ahmadi, Hessam and Ahmed, Nisar and Sid, Farid Ahmed and Ai, Edward and Ai, Qing and Aicha, Benyahia and Aitharaju, Sai and Aiyer, Aditya and Akkus, Zeynettin and Akodad, Sanae and Akramifard, Hamid and Aksman, Leon and Aktas, Said and Al-Janabi, Omar and Al-Nuaimi, Ali and AlAila, BahaaEddin and Alakwaa, Fadhl and Alam, Saruar and Alam, Fakhre and Alam Zaidi, Syed Farhan and Alan, Wiener and Alansari, Mukhtar and Alareqi, Ebrahim and Alberdi, Ane and Albsoul, Mohammad and Alderson, Thomas and Aleem, Hassan and Alex, Aishwarya and Alexander, Jacob and Alexopoulos, Panagiotis and Alfoldi, Jessica and Ali, Ayesha and Ali, Imdad and Alimoradian, Shirin and Aljabar, Paul and Aljabbouli, Hasan and Aljovic, Almir and Allen, Genevera and Alliende, Luz Maria and Almaguel, Frankis and Almgren, Hannes and Montes, Carmen Alonso and Alowaisheq, Tasneem and Alryalat, Saif Aldeen and Alsado, Majd and Alsaedi, Abdalrahman and Alshehri, Haifa and Altaf, Tooba and Altendahl, Marie and Altmann, Ane and Alvand, Ashkan and Filho, Manoel Alves and Alzubi, Raid and Amaral, Robert and Ambatipudi, Mythri and Amernath, Remya and Amlien, Inge and Amoroso, Nicola and Amri, Hakima and Anastasiou, Athanasios and Anbarasi, Jani and Anbarjafari, Gholamreza and Anderson, Wes and ... and Alzheimer's Dis Neuroimaging and Alzheimer's Disease Neuroimaging Initiative and The Alzheimer's Disease Neuroimaging Initiative
Frontiers in aging neuroscience, ISSN 1663-4365, 2017, Volume 9, Issue MAY, p. 146
Journal Article